Russell B. Kerbel

Russell Kerbel practices at Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health.

Russell Kerbel's NPI, 1164699203, was assigned on May 8, 2008. Russell Kerbel graduated from Tufts University School Of Medicine in 2008. Russell Kerbel holds California license A128689.

Russell Kerbel's primary practice is Ronald Reagan UCLA Medical Center, at 757 Westwood Plaza, Los Angeles, CA 90095 in Los Angeles County. The practice phone is (310) 825-6301.

Russell Kerbel's primary practice is Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health. Russell Kerbel is also affiliated with UCLA Santa Monica Medical Center. The medical group on file is UCLA Medical Group.

Dmand AI tracks the electronic health record (EHR) system at each site where Russell Kerbel practices, 2 sites in all. Vendor and product names are available with a free account.

Hospitalist is Russell Kerbel's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Russell Kerbel is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Russell Kerbel's licenses on file in 3 states: California, Florida and Massachusetts.

Dmand AI lists cellulitis, gastrointestinal inflammation, heart attack, lung disease: COPD, asthma or bronchitis and sepsis among the conditions Russell Kerbel treats.

CMS data shows 122 Medicare services from Russell Kerbel across 4 procedure codes in 2024, for 54 Medicare patients. Medicare paid $11,346 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 54 Medicare patients who saw Russell Kerbel in 2024. The largest group is 65 to 74, with 23 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 50% are also on Medicaid. Their average risk score is 3.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Russell Kerbel's median patient age at 58, with 38% women.

In 2024, Russell Kerbel wrote 22 Medicare Part D claims. 86% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $124 in total drug cost. In 2017, CMS named 25 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Russell Kerbel for performance year 2024, reported as part of a group. Russell Kerbel accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 7 papers to Russell Kerbel, published from 2014 to 2019. 2015 was the busiest year, with 2. Russell Kerbel has published most often in Healthc (Amst). Russell Kerbel's most frequent co-authors are Kiran Kakarala, MD, Joshua Will Allen-Dicker, MD, MPH and Khin-Kyemon Aung, MBA, MD.

CMS Open Payments shows 13 general payments to Russell Kerbel from 4 drug and device companies from 2018 to 2025. Consulting fees make up the largest share, 70% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $6,375.

Russell Kerbel graduated from Tufts University School Of Medicine in 2008. Russell Kerbel is a member of SHM.

Russell Kerbel is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.